Back

Regeneron Pharmaceuticals Stock Predictions

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Sell

REGN
Regeneron Pharmaceuticals

Last Price:

742.92

Seasonality Move:

14.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Regeneron Pharmaceuticals Stock Forecast

Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 27.1% based on the past 33 years of stock performance.
Regeneron Pharmaceuticals has risen higher in 20 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.61%
Is Regeneron Pharmaceuticals Stock Undervalued?
The current Regeneron Pharmaceuticals [REGN] share price is $743.35. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Regeneron Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 27.1% based on the past 33 years of stock performance.

Regeneron Pharmaceuticals Stock Rating

Sell

Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals overpriced?

Regeneron Pharmaceuticals has risen higher in 20 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.61%

Regeneron Pharmaceuticals Stock Price History

Is REGN stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

S&P500

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

regeneron.com

52-Week Data

52-Week High:

1,211.20

52-Week Low:

750.20

Prediction Charts

Market Cap:

81.69B

Price in USD:

743.35

Volume:

651.76K

Beta:

0.96

Technical Analysis

SMA50:

964.64

SMA100:

1,039.60

SMA200:

1,003.34

52-Wk Change:

-7.27%

Stock Predictions

Is Regeneron Pharmaceuticals stock public?
Yes, Regeneron Pharmaceuticals is a publicly traded company.
What is the Regeneron Pharmaceuticals stock quote today?
The Regeneron Pharmaceuticals stock price is 743.35 USD today.
How to buy Regeneron Pharmaceuticals stock online?
You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-1	844.61	843.60	862.00	837.88
Nov-4	845.59	828.87	852.01	826.76
Nov-5	824.94	829.43	836.63	819.14
Nov-6	844.51	816.65	844.51	813.53
Nov-7	817.88	824.48	832.53	814.05
Nov-8	826.57	828.42	830.73	822.80
Nov-11	824.00	825.68	834.42	820.45
Nov-12	824.31	821.00	831.00	817.14
Nov-13	815.45	804.33	823.56	803.33
Nov-14	800.15	782.51	803.42	780.95
Nov-15	782.78	756.81	783.10	753.69
Nov-18	751.97	762.00	762.70	750.20
Nov-19	756.56	744.60	758.60	736.19
Nov-20	742.19	743.35	750.69	736.01

Regeneron Pharmaceuticals Earnings

Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Regeneron Pharmaceuticals Forecast Revenue Growth

Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.

* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.